Amedisys Inc.

NASDAQ: AMED · Real-Time Price · USD
100.99
0.01 (0.01%)
At close: Aug 14, 2025, 3:59 PM

Amedisys Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.35B 2.24B 2.22B 2.21B
Cost of Revenue
1.33B 1.25B 1.26B 1.23B
Gross Profit
1.02B 990.87M 962.77M 980.76M
Operating Income
94.54M 156.39M 180.77M 251.91M
Interest Income
8.11M 3.27M 178K 49K
Pretax Income
86.22M 39.62M 160.24M 280.23M
Net Income
43.23M -9.75M 118.61M 209.07M
Selling & General & Admin
790.11M 780.06M 754.06M 711.24M
Research & Development
n/a 3.8M 3M n/a
Other Expenses
133.03M 50.62M 24.93M 17.6M
Operating Expenses
923.14M 834.48M 778.99M 728.84M
Interest Expense
30.76M 31.27M 22.23M 9.53M
Selling & Marketing Expenses
n/a 516.05M n/a n/a
Cost & Expenses
2.25B 2.08B 2.04B 1.96B
Income Tax Expense
48.05M 50.56M 42.55M 70.06M
Shares Outstanding (Basic)
32.72M 32.49M 32.52M 32.64M
Shares Outstanding (Diluted)
33.05M 32.6M 32.65M 32.97M
EPS (Basic)
1.32 -0.3 3.65 6.41
EPS (Diluted)
1.31 -0.3 3.63 6.34
EBITDA
73.45M 216.91M 207.41M 320.66M
EBIT
55.45M 193.07M 182.47M 289.76M
Depreciation & Amortization
18M 23.85M 24.93M 30.9M